当前位置: 首页 > 期刊 > 《中国当代医药》 > 2019年第32期
编号:13440058
烟台市2015~2017年药品不良反应报告分析(3)
http://www.100md.com 2019年11月15日 《中国当代医药》 2019年第32期
     [15]錢先中,金惠静,杨娟,等.药品不良反应报告分析[J].中国医药,2015,10(4):573-577.

    [16]郑芳芳,赵园园,叶露,等.215例临床药品不良反应分析[J].宁夏医科大学学报,2017,39(7):802-805.

    [17]蔡蕴敏,方欢.我院1005例药品不良反应报告分析[J].中国药房,2015,26(11):1509-1513.

    [18]蔡萍,顾平荣.2009年度扬州某三甲医院308例药品不良反应统计分析[J].黑龙江医药,2010,23(3):379-382.

    [19]姚志红,刘英,詹煦旭,等.我院2012~2015年抗菌药物不良反应分析[J].中国当代医药,2016,23(17):136-138.

    (收稿日期:2019-03-26 本文编辑:任秀兰)

    1. Department of Pharmacy, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Shandong Province, Yantai 264000, China; 2. Yantai Adverse Drug Reaction Monitoring Center, Shandong Province, Yantai 264000, China

    [Abstract] Objective To summarize and analyze the adverse drug reaction (ADR) of Yantai city from 2015 to 2017, and to provide reference and basis for drug safety monitoring and clinical rational and safe use of drugs. Methods A retrospective study was conducted to analyze the data of 31 954 ADR statements in Yantai city from 2015 to 2017. Results Among the 31 954 cases of ADR, intravenous drip was the main route of adverse reactions, for 17 917 cases (56.07%). Patients over 59 years accounted for the largest proportion, with a total of 12 698 cases (39.74%). The most high frequency of adverse reactions was anti-microbial drugs, which caused a total of 8796 cases of adverse reactions, accounting for 27.53%. Of all the ADR reports, gastrointestinal system was the most frequent, with a total of 11 601 cases, accounting for 26.94%. Of all ADR, 18 833 cases were cured after treatment, accounting for 58.94%. The completion of the adverse reaction report was not complete, and the quality of the filling needed to be improved. Conclusion More attention should be paid to the report filling and monitoring of ADR, so as to reduce or avoid the occurrence of ADR and ensure safety and rationality of drug use in clinic.

    [Key words] Adverse drug reaction; Report analysis; Monitoring; Rational use of drugs, 百拇医药(郝梓君 唐启令 丁月霞 周芙蓉 郑文文 尹爱群)
上一页1 2 3